Related references
Note: Only part of the references are listed.Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Rupa Juthani et al.
CLINICAL CANCER RESEARCH (2020)
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma
Antje Wick et al.
NEURO-ONCOLOGY (2020)
SRC Kinase in Glioblastoma: News from an Old Acquaintance
Claudia Cirotti et al.
CANCERS (2020)
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma
Wolfgang Wick et al.
NEURO-ONCOLOGY (2019)
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872
Evanthia Galanis et al.
CANCER (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Roles of the endoplasmic reticulum-resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease
Shinya Ito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
John M. Lamar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match ((NM2)-M-2) pilot study
Elke Pfaff et al.
NEURO-ONCOLOGY (2018)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment (vol 32, pg 42, 2017)
Qianghu Wang et al.
CANCER CELL (2018)
The heat shock protein 47 as a potential biomarker and a therapeutic agent in cancer research
Beatriz Dal Pont Duarte et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Johanna Klughammer et al.
NATURE MEDICINE (2018)
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Satoshi Noguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
Tony Avril et al.
CLINICAL CANCER RESEARCH (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
G. Marziali et al.
SCIENTIFIC REPORTS (2016)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Src family kinases differentially influence glioma growth and motility
Laura J. Lewis-Tuffin et al.
MOLECULAR ONCOLOGY (2015)
Dasatinib in recurrent glioblastoma: failure as a teacher
David Schiff et al.
NEURO-ONCOLOGY (2015)
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
Andrew B. Lassman et al.
NEURO-ONCOLOGY (2015)
Kinome-wide shRNA Screen Identifies the Receptor Tyrosine Kinase AXL as a Key Regulator for Mesenchymal Glioblastoma Stem-like Cells
Peng Cheng et al.
STEM CELL REPORTS (2015)
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma
Jennie W. Taylor et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Heat shock protein 47 regulated by miR-29a to enhance glioma tumor growth and invasion
Dan Zhao et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Identification of Kinase Inhibitor Targets in the Lung Cancer Microenvironment by Chemical and Phosphoproteomics
Manuela Gridling et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
Identification of Targets of c-Src Tyrosine Kinase by Chemical Complementation and Phosphoproteomics
Isabel Martinez Ferrando et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Targeting SRC in glioblastoma tumors and brain metastases Rationale and preclinical studies
Manmeet S. Ahluwalia et al.
CANCER LETTERS (2010)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Lonneke A. M. Gravendeel et al.
CANCER RESEARCH (2009)
Improving the prognosis for patients with glioblastoma: the rationale for targeting Src
John de Groot et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib
Ying Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells
X Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
